The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis.

MLA

Gineyts, Evelyne, et al. “The C-Terminal Intact Forms of Periostin (IPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis.” Calcified Tissue International, vol. 103, no. 5, Nov. 2018, pp. 567–80. EBSCOhost, https://doi.org/10.1007/s00223-018-0444-y.

APA

Gineyts, E., Bonnet, N., Bertholon, C., Millet, M., Pagnon-Minot, A., Borel, O., Geraci, S., Bonnelye, E., Croset, M., Suhail, A., Truica, C., Lamparella, N., Leitzel, K., Hartmann, D., Chapurlat, R., Lipton, A., Garnero, P., Ferrari, S., Clézardin, P., & Rousseau, J.-C. (2018). The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis. Calcified Tissue International, 103(5), 567–580. https://doi.org/10.1007/s00223-018-0444-y

Chicago

Gineyts, Evelyne, Nicolas Bonnet, Cindy Bertholon, Marjorie Millet, Aurélie Pagnon-Minot, Olivier Borel, Sandra Geraci, et al. 2018. “The C-Terminal Intact Forms of Periostin (IPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone Metastasis.” Calcified Tissue International 103 (5): 567–80. doi:10.1007/s00223-018-0444-y.